<ѻý>FDA Drops Boxed Warning From Invokana Labelѻý> Amputation risk "lower than previously described" Aug 27, 2020
<ѻý>Diabetes Drugs Looking for Broad Role in COVID-19ѻý> The mechanisms check out and trials are underway Aug 24, 2020
<ѻý>Healthy People 2030: HHS Prioritizes Socioeconomic Disparities, Overall Well-Beingѻý> New national health goals for the next decade Aug 20, 2020
<ѻý>DPP-4 Inhibitors Tied to Blistering Skin Conditionѻý> Increased risk for bullous pemphigoid modified by patient age, race Jul 22, 2020
<ѻý>A Diabetes Drug That Slows Cognitive Decline?ѻý> Trulicity analysis hints at dementia prevention Jun 22, 2020
<ѻý>Ertugliflozin Tx: Safe for the Heart in Patients With T2Dѻý> Phase III VERTIS-CV trial meets primary endpoint of MACE non-inferiority Jun 17, 2020
<ѻý>NDMA Prompts Metformin Recallѻý> FDA finds certain products with excessive levels of potential carcinogen May 29, 2020
<ѻý>Drugs Helped Stop Weight Regain After Gastric Bypassѻý> Half of patients in retrospective study regained a third of lost weight May 27, 2020
<ѻý>Miscarriage: Predictive of Type 2 Diabetes?ѻý> Whether such a link is due to underlying metabolic conditions, however, is still to be determined May 21, 2020
<ѻý>COVID-19 Further Strains Care Disparities Among Native Americansѻý> Underfunded IHS, isolation from resources pose major concern for tribes during pandemic May 21, 2020
<ѻý>An Argument for Losing Weight Prior to Bariatric Surgeryѻý> Study suggests reduction in already low mortality risk May 14, 2020
<ѻý>Cold-Induced Energy Burn Higher With Brown Fatѻý> More evidence of the tissue's potential as target for weight loss, researchers say Apr 28, 2020
<ѻý>Metformin Appears to Shield Diabetic Patients From Post-Op Deathѻý> Similar to statins, with anti-inflammatory properties suggested as explanation Apr 09, 2020
<ѻý>Minimally Invasive DMR Scores a Win in T2Dѻý> Outpatient duodenal mucosal resurfacing procedure showed broad range of metabolic benefits Mar 31, 2020
<ѻý>Higher On-Tx EPA Levels Explain Benefit of Vascepaѻý> Further evidence from REDUCE-IT that triglyceride lowering is not key to icosapent ethyl's effects Mar 30, 2020
<ѻý>NKF 2020: New Lupus Tx; Staying on Spironolactone, and Moreѻý> Research highlights from the National Kidney Foundation virtual meeting Mar 30, 2020
<ѻý>TWILIGHT Findings Hold Strong in Diabetes, Complex PCIѻý> Ticagrelor monotherapy after brief DAPT also worked following newer-gen stent implantation Mar 30, 2020
<ѻý>Ultra-Processed Foods: It's Not Just Sugar and Fat Attacking Waistlinesѻý> The Skeptical Cardiologist reviews the evidence Mar 07, 2020
<ѻý>Workplace Wellness Program Triumphs for Hypertensionѻý> Two-thirds meet blood pressure target after 2 years Mar 04, 2020
<ѻý>Diabetes Drug May Benefit Long-Term Steroid Usersѻý> Metformin improved metabolic profile in patients with chronic inflammatory disease Feb 25, 2020
<ѻý>What Lorcaserin Did for Meѻý> Journalist who used weight-loss drug for a year -- and lost a lot of weight -- reflects on the recent news Feb 14, 2020
<ѻý>Entresto Data Support Wider Reach of 'Fifth Pillar' HF Drugѻý> Benefits observed beyond HF patients with reduced EF Nov 17, 2019
<ѻý>Apabetalone Falls Short in Patients With T2D and ACSѻý> Trial of BET protein inhibitor likely underpowered to show benefit Nov 17, 2019
<ѻý>HF Benefit of Dapagliflozin Affirmed in Non-Diabeticsѻý> Fewer CV events for heart failure with reduced ejection fraction Nov 16, 2019
<ѻý>Time to Rethink BMI Cutoff for Bariatric Surgery?ѻý> The point isn't weight loss, researcher argues, but treatment for diabetes, hypertension, and other comorbidities Nov 06, 2019
<ѻý>Why the Lower Risk of Prostate Cancer in Men With Diabetes?ѻý> Findings from large cohort study do not support one leading hypothesis, researchers say Nov 06, 2019
<ѻý>Meal Replacement Upped Weight Loss for Obese Postmenopausal Womenѻý> Caveat, though, that benefits came at price of bone loss, study finds Oct 30, 2019
<ѻý>The 'Bedtime Snack' for Inmates With Diabetesѻý> Where do they get the idea that it's standard medical care? Oct 24, 2019
<ѻý>Conjugate Active in Exudative Retinal Diseasesѻý> Improved vision, decreased retinal thickening with antibody-biopolymer agent Oct 13, 2019
<ѻý>Dapagliflozin: More Good News in HFѻý> SGLT-2 inhibitor advantage in DAPA-HF extended across T2D status, ARNI use Sep 19, 2019
<ѻý>Bariatric Surgery Tied to Better Cardiometabolic Health Down the Roadѻý> Improvements beyond risk factor reduction in patients with T2D and obesity Sep 02, 2019
<ѻý>Dapagliflozin Benefits HFrEF Outcomes, Even Without Diabetesѻý> DAPA-HF trial affirms similar benefit to diabetes drug regardless of type 2 diabetes status Sep 01, 2019 video
<ѻý>Extended DAPT with Brilinta: No Benefit for Stable CAD in T2Dѻý> Substudy in those with prior PCI might identify group where bleeding tradeoff is worthwhile Sep 01, 2019
<ѻý>Osteoporosis Drug Wins; Tramadol and Blood Sugarѻý> News and commentary from the endocrinology world Aug 30, 2019
<ѻý>GLP-1 RA Benefits Extend Beyond MACE Reductionѻý> Meta-analysis pooled data on all major outcomes trials for agent class Aug 16, 2019
<ѻý>No Added CV Risk for Oral Semaglutide in T2Dѻý> Safety study buffs resume for oral GLP-1 receptor agonist Jun 11, 2019
<ѻý>Urine Marker Predicts Kidney Benefit With Trulicityѻý> Secondary AWARD-7 analysis finds subgroup getting the most renal protection Jun 11, 2019
<ѻý>Dapagliflozin Boosts Renal Function in T2Dѻý> Secondary outcomes build on previously reported cardiovascular benefit from SGLT2 inhibitors Jun 10, 2019
<ѻý>Another GLP-1 Agent Cuts Heart Risk in T2Dѻý> Dulaglutide added to the growing list of diabetes treatments to show added benefit Jun 10, 2019